These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10948698)

  • 21. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of bone mass in forearm, lumbar vertebra and hip by single and/or dual energy X-ray absorptiometry.
    Qin M; Lin S; Song Z; Tian J; Chen F; Yan H; Ge Q
    Chin Med Sci J; 1999 Jun; 14(2):117-20. PubMed ID: 12901622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density improvement after successful parathyroidectomy in pre- and postmenopausal women with primary hyperparathyroidism: a prospective study.
    Lumachi F; Camozzi V; Ermani M; DE Lotto F; Luisetto G
    Ann N Y Acad Sci; 2007 Nov; 1117():357-61. PubMed ID: 17646261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired vascular function in exercising anovulatory premenopausal women is associated with low bone mineral density.
    O'Donnell E; Scheid JL; West SL; De Souza MJ
    Scand J Med Sci Sports; 2019 Apr; 29(4):544-553. PubMed ID: 30548536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vitamin D receptor gene polymorphism and the rate of bone loss of the femur neck and lumbar spine in hemodialized patients with chronic renal failure].
    Karkoszka H; Chudek J; Strzelczyk P; Wiecek A; Schmidt-Gayk H; Ritz E; Kokot F
    Pol Merkur Lekarski; 1998 Oct; 5(28):199-202. PubMed ID: 10101442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism.
    Abdelhadi M; Nordenström J
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3845-51. PubMed ID: 9814456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease.
    Fidan N; Inci A; Coban M; Ulman C; Kursat S
    J Investig Med; 2016 Apr; 64(4):861-6. PubMed ID: 26969749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
    Legroux-Gerot I; Vignau J; Collier F; Cortet B
    Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
    Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
    Sawada K; Morishige K; Ohmichi M; Nishio Y; Yamamoto T; Hayakawa J; Mabuchi S; Isobe A; Sasaki H; Sakata M; Tasaka K; Murata Y
    Maturitas; 2007 Apr; 56(4):343-9. PubMed ID: 17010541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters.
    Rochira V; Faustini-Fustini M; Balestrieri A; Carani C
    J Clin Endocrinol Metab; 2000 May; 85(5):1841-5. PubMed ID: 10843162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Decreased bone mineral density in premenopausal women with amenorrhea].
    Kinoshita T; Yasumizu T; Kato J
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):793-8. PubMed ID: 8841045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
    Cundy T; Ames R; Horne A; Clearwater J; Roberts H; Gamble G; Reid IR
    J Clin Endocrinol Metab; 2003 Jan; 88(1):78-81. PubMed ID: 12519833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
    Warming L; Ravn P; Christiansen C
    Maturitas; 2005 Feb; 50(2):78-85. PubMed ID: 15653003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormonal activity of the hypophysial-gonadal axis versus the mineral bone density and specific markers of bone turnover in haemodialysis population].
    Kurnatowska I; Zygmunt A; Fijałkowska-Morawska J; Białkowska J; Jabłkowski M; Nowicki M; Lewiński A
    Pol Merkur Lekarski; 2006 Apr; 20(118):408-12. PubMed ID: 16886562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life.
    Sugiya N; Nakashima A; Takasugi N; Kawai A; Kiribayashi K; Tanaka J; Kohno N; Yorioka N
    Osteoporos Int; 2011 May; 22(5):1573-9. PubMed ID: 20652228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone turnover markers and bone density across the menopausal transition.
    Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parathyroid hormone(1-84) treatment of postmenopausal women with low bone mass receiving hormone replacement therapy.
    Fogelman I; Fordham JN; Fraser WD; Spector TD; Christiansen C; Morris SA; Fox J
    Calcif Tissue Int; 2008 Aug; 83(2):85-92. PubMed ID: 18626566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.